Danaher Corporation DHR
Verdict: Strong sell. Fair value $211 against a price of $235 on 6 Jan 2026, 11% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. From FY2022 to FY2024, revenue declined by approximately 10% (from $26.64B to $23.88B). However,....
Main risks
- Negative Growth and Profit Decline: Revenue has stagnated and Net Income has declined for two consecutive years (from $7.21B in 2022 to $3.90B in 2024), indicating significant business headwinds or margin pressure.
- Poor Recent Capital Allocation (Negative ROIIC): Proxied calculations show a negative 3-year Return on Incremental Invested Capital (-4.1%), suggesting that recent investments have been value-destructive.
- Deteriorating Return Metrics: Key metrics like ROE (7.9%) and ROIC (6.6%) are low for a company of this caliber and have likely fallen sharply, indicating capital is being employed less efficiently than in the past.
- From FY2022 to FY2024, revenue declined by approximately 10% (from $26.64B to $23.88B). However,...
- Intense competitive environment
- From FY2022 to FY2024, revenue declined by approximately 10% (from $26.64B to $23.88B). However, over the same period, Net Income plummeted by 46% (from $7.21B to $3.90B). This disproportionate drop in profitability suggests significant margin pressure or, more likely, the presence of large non-cash charges such as impairments or restructuring costs hitting the income statement.